HONG KONG, Feb. 20, 2018 -- Value Exchange International, Inc. (OTCQB:VEII) (“VEII”), a retail technology and computer systems services provider, announced today that Value Exchange Int’l (Shanghai) Limited, a wholly owned subsidiary of VEII, (“VEII Sub”) signed a January 24, 2018 stores equipment support agreement (“Agreement”) with the largest health care and beauty retailer (“Retailer”) in People’s Republic of China (“China”). Under the Agreement, the Retailer has contracted for site and preventive maintenance and support for computer and point of sale systems (“Systems”) as well as new store and store renovation install and migration services for Systems from the VEII Sub. The Agreement is non-exclusive, covers Retailer’s stores in the northern and eastern region of China and runs through December 2019.
Gross revenue and net profit potential, if any, as well as the full extent of services by VEII Sub under the Agreement are uncertain at this time due to lack of sufficient operational experience as a service provider under the Agreement. The Company anticipates reporting initial financial results and projected financial results for the VEII Sub work under the Agreement with the announcement of the quarterly consolidated financial results for VEII’s fiscal quarter ending March 31, 2018. Actual extent of services and financial results of the services may vary from any projected or anticipated scope of services and related financial results.
“These new services contract reflect progress in our efforts to grow VEII to the next level of development and to establish a public company capable of enhancing shareholder value and liquidity. Our goal is to reach sustained profitability and steady growth in core business segments through new business from new and existing customers as well as from expansion in new markets,” said Kenneth Tan, Value Exchange’s Chief Executive Officer. “This new work, which is in part a continuation of previous services for the same end user, attest to the value and competency of our services,” Mr. Tan added.
INVESTOR/MEDIA CONTACT: Matthew Mecke, Value Exchange IR Director ir(@)value-exch.com


Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Goldman Sachs Sees US Stock Buybacks Outpacing Equity Issuance as AI Funding Rises
OpenAI Restricts Astra AI Over Cyberattack Risks
ADNOC Gas Targets Up to $4B Profit in 2026
Sony, TSMC Eye $6.3 Billion Japan Chip Venture for Next-Gen Image Sensors
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook
Shein Scales Back Vietnam Operations as US Trade Rules Shift
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
Apple Tests China’s CXMT Memory Chips for iPhones and MacBooks Amid AI Supply Crunch 



